Author:
Honda Mutsuko,Toyoda Wakako,Shimizu Takako,Horiuchi Isao,Kayano Yuichiro,Taguchi Masato,Nozawa Takashi,Inoue Hiroshi,Hashimoto Yukiya
Publisher
Japanese Society for the Study of Xenobiotics
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference7 articles.
1. Assay and disposition of carvedilol enantiomers in humans and monkeys: evidence of stereoselective presystemic metabolism;Fujimaki;J. Pharm. Sci.,1990
2. In vitro identification of the human cytochrome P450 enzymes involved in the metabolism of R( + )- and S(−)-carvedilol;Oldham;Drug Metab. Dispos.,1997
3. Involvement of human hepatic UGT1A1, UGT2B4, and UGT2B7 in the glucuronidation of carvedilol;Ohno;Drug Metab. Dispos.,2004
4. Multiple regression analysis of pharmacogenetic variability of carvedilol disposition in 54 healthy Japanese volunteers;Honda;Biol. Pharm. Bull.,2006
5. Contribution of polymorphisms in UDP-glucuronosyltransferase and CYP2D6 to the individual variation in disposition of carvedilol;Takekuma;J. Pharm. Pharm. Sci.,2006
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献